MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health Regulatory Agency (Agencia Nacional de Vigilancia Sanitaria or 'ANVISA') has approved Illuccix®...
Hence then, the article about illuccix approved for prostate cancer imaging in brazil first marketing authorization in latin america was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America )
Also on site :
- Disgraced former Centinela Valley schools Superintendent Jose Fernandez dies
- Outsiders see a circular economy. CoreWeave’s CEO sees a ‘violent change’ rattling the supply chain down to the inside of the earth
- As millions of Gen Zers face unemployment, CEOs of Amazon, Walmart, and McDonald’s say opportunity is still there—if you have the right mindset